Selected Publications
1. Jetiyanon, K., Wittaya-Areekul, S., Plianbangchang, P., & Lohitnavy, O. (2017). “Rhizoproduct”, a biofertilizer containing spores of Bacillus cereus strain RS87 for early rice seedling enhancement and with potential for partial fertilizer substitution. Songklanakarin Journal of Science and Technology, 39(1), 109-116. doi: 10.14456/sjst-psu.2017.12
2. Lohitnavy, M., Chitsakhon, A., Jomprasert, K., Lohitnavy, O., & Reisfeld, B. (2017). Development of a physiologically based pharmacokinetic model of paraquat. Paper presented at the Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS.
3. Lohitnavy, M., Lu, Y., Lohitnavy, O., & Yang, R. S. H. (2017). A physiologically-based pharmacokinetic model of methotrexate incorporating hepatic excretion via multidrug-resistance-associated protein 2 (Mrp2) in mice, rats, dogs, and humans. Paper presented at the Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS.
4. Methaneethorn, J., & Lohitnavy, M. (2018). External evaluation of a published population pharmacokinetic model of valproic acid in Thai manic patients. European Journal of Hospital Pharmacy. doi: 10.1136/ejhpharm-2018-001653
5. Sookying, S., Pekthong, D., Oo-Puthinan, S., Nuengchamnong, N., & Ingkaninan, K. (2017). Quantitation of Bacopaside i in rat biological samples by LC-QTOF-MS/MS and its pharmacokinetic application. Natural Product Communications, 12(6), 893-896.
6. Sookying, S., Pekthong, D., Oo-puthinan, S., Phrompittayarat, W., Putalun, W., Tanaka, H., . . . Ingkaninan, K. (2017). Immunochromatographic determination of bacopaside I in biological samples. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1040, 60-66. doi: 10.1016/j.jchromb.2016.11.022
7. Sukasem, C., Chaichan, C., Nakkrut, T., Satapornpong, P., Jaruthamsophon, K., Jantararoungtong, T., . . . Aekplakorn, W. (2018). Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients. Journal of Immunology Research, 2018. doi: 10.1155/2018/2780272
8. Tangamornsuksan, W., Kongkaew, C., Scholfield, C. N., Subongkot, S., & Lohitnavy, M. (2019). HLA-DRB1*07:01 and lapatinib-induced hepatotoxicity: a systematic review and meta-analysis. Pharmacogenomics Journal. doi: 10.1038/s41397-019-0092-2
9. Tangamornsuksan, W., & Lohitnavy, M. (2018). Association between HLA-B*1301 and dapsone-induced cutaneous adverse drug reactions a systematic review and meta-analysis. JAMA Dermatology, 154(4), 441-446. doi: 10.1001/jamadermatol.2017.6484
10. Tangamornsuksan, W., & Lohitnavy, M. (2019). Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis. Pharmacogenomics Journal, 19(3), 286-294. doi: 10.1038/s41397-018-0052-2
11. Tangamornsuksan, W., Lohitnavy, O., Sruamsiri, R., Chaiyakunapruk, N., Norman Scholfield, C., Reisfeld, B., & Lohitnavy, M. (2019). Paraquat exposure and Parkinson’s disease: A systematic review and meta-analysis. Archives of Environmental and Occupational Health, 74(5), 225-238. doi: 10.1080/19338244.2018.1492894
12. Tangamornsuksan, W., Scholfield, C. N., & Lohitnavy, M. (2018). Association between HLA genotypes and oxcarbazepine-induced cutaneous adverse drug reactions: A systematic review and meta- analysis. Journal of Pharmacy and Pharmaceutical Sciences, 21(1), 1-18. doi: 10.18433/J36S7D
13. Tangamornsuksan, W., Thiansupornpong, P., Morasuk, T., Lohitnavy, O., & Lohitnavy, M. (2017). A pharmacokinetic model of drug-drug interaction between clopidogrel and omeprazole at CYP2C19 in humans. Paper presented at the Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS.
14. Tran, Q. B., Lohitnavy, M., & Phenrat, T. (2019). Assessing potential hydrogen cyanide exposure from cyanide-contaminated mine tailing management practices in Thailand's gold mining. Journal of Environmental Management, 249. doi: 10.1016/j.jenvman.2019.109357
15. Tran, Q. B., Phenrat, T., & Lohitnavy, M. (2019). Physiologically based pharmacokinetic modeling of hydrogen cyanide in humans following the oral administration of potassium cyanide and cyanogenic glycosides from food. Human and Ecological Risk Assessment. doi: 10.1080/10807039.2019.1587288
16. Ya, K., Tangamornsuksan, W., Scholfield, C. N., Methaneethorn, J., & Lohitnavy, M. (2019). Pharmacokinetics of mitragynine, a major analgesic alkaloid in kratom (Mitragyna speciosa): A systematic review. Asian Journal of Psychiatry, 43, 73-82. doi: 10.1016/j.ajp.2019.05.016
17. Kongkaew, C., Methaneethorn, J., Mongkhon, P., Dechanont, S., & Taburee, W. (2017). Drug-Related Problems Identified at Patientsʼ Home: A Prospective Observational Study in a Rural Area of Thailand. Journal of Patient Safety.
18. Methaneethorn, J. (2017). Population Pharmacokinetics of Valproic Acid in Patients with Mania: Implication for Individualized Dosing Regimens. Clinical Therapeutics, 39(6), 1171-1181.
19. Methaneethorn, J. (2018). Population Pharmacokinetic Analyses of Lithium: A Systematic Review. European Journal of Drug Metabolism and Pharmacokinetics, 43(1), 25-34.
20. Methaneethorn, J. (2018). A systematic review of population pharmacokinetics of valproic acid. British Journal of Clinical Pharmacology, 84(5), 816-834.
21. Methaneethorn, J., Panomvana, D., & Vachirayonstien, T. (2017). Preliminary study of the association between the elimination parameters of phenytoin and phenobarbital. Drug Metabolism and Personalized Therapy, 32(3), 151-156.
22. Methaneethorn, J., & Sringam, S. (2019). Factors influencing lithium pharmacokinetics in patients with acute mania: A population pharmacokinetic analysis. Human Psychopharmacology, 34(3).
23. Panomvana, D., Methaneethorn, J., & Vachirayonstien, T. (2017). Correlation Between Elimination Parameters of Phenytoin and Carbamazepine in Patients with Epilepsy Receiving Both Drugs Concomitantly: A Preliminary Study. Pharmaceutical Medicine, 31(2), 119-124.
24. วิธู ดิลกธรสกุล, ดำรงศักดิ์ เป๊กทอง, จันทิมา เมทนีธร, สกลวรรณ ประพฤติบัติ, ปิยะเมธ ดิลกธรสกุล. (2561). ประสิทธิผลของกิจกรรมทบทวนความรู้แบบเป็นระบบต่อผลสัมฤทธิ์ทางการเรียน ของผู้เรียนในรายวิชาเภสัชวิทยาเบื้องต้น. วารสารเภสัชกรรมไทย, 10(2), 402-410.
25. Lohitnavy M, Chitsakhon A, Jomprasert K, Lohitnavy O, Reisfeld B. Development of a physiologically based pharmacokinetic model of paraquat. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS; 2017.
26. Lohitnavy M, Lu Y, Lohitnavy O, Yang RSH. A physiologically-based pharmacokinetic model of methotrexate incorporating hepatic excretion via multidrug-resistance-associated protein 2 (Mrp2) in mice, rats, dogs, and humans. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS; 2017.
27. Tangamornsuksan W, Thiansupornpong P, Morasuk T, Lohitnavy O, Lohitnavy M. A pharmacokinetic model of drug-drug interaction between clopidogrel and omeprazole at CYP2C19 in humans. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS; 2017.
28.Methaneethorn, J., & Lohitnavy, M. (2020). External evaluation of a published population pharmacokinetic model of valproic acid in Thai manic patients. European Journal of Hospital Pharmacy, 27(3), 168-172.
29.Methaneethorn, J., Lohitnavy, M., & Leelakanok, N. (2020). A Systematic Review of Population Pharmacokinetics of Carbamazepine. Systematic Reviews in Pharmacy, 11(10), 653-673.
30.Methaneethorn, J., Naosang, K., Kaewworasut, P., Poomsaidorn, C., & Lohitnavy, M. (2020). Development of a Physiologically-Based Pharmacokinetic Model of Δ9-Tetrahydrocannabinol in Mice, Rats, and Pigs. European Journal of Drug Metabolism and Pharmacokinetics, 45(4), 487-494.
31.Methaneethorn, J., Poomsaidorn, C., Naosang, K., Kaewworasut, P., & Lohitnavy, M. (2020). A Δ9-Tetrahydrocannabinol Physiologically-Based Pharmacokinetic Model Development in Humans. European Journal of Drug Metabolism and Pharmacokinetics, 45(4), 495-511.
32.Ya, K., Methaneethorn, J., Tran, Q. B., Trakulsrichai, S., Wananukul, W., & Lohitnavy, M. (2021). Development of a Physiologically Based Pharmacokinetic Model of Mitragynine, Psychoactive Alkaloid in Kratom (Mitragyna Speciosa Korth.), In Rats and Humans. Journal of Psychoactive Drugs, 53(2), 127-139.
33. ประพน เพ็ญสมบูรณ์, นิชนันท์ เจริญวงศ์, ปฐพงศ์ โตวิวัฒน์, และภัควดี เสริมสรรพสุข. (2563). ผลของระยะห่างของการให้ยาในแผนกำหนดการใช้ยาเมโทเทร็กเซตในผู้ป่วยโรคข้อ อักเสบรูมาตอยด์ต่อความน่าจะเป็นในการบรรลุระดับยาเป้าหมายโดยการจำลอง มอนติคาร์โล. วารสารเภสัชวิทยา, 42(1), 20-35.
34. Danwilai, K., Lohitnavy, O, Sakunrag, I, & Dilokthornsakul, P. (2021). The effect of magnesium supplementation on cisplatin induced nephrotoxicity: A systematic review and meta-analysis. Pharm Sci Asia 2021; 48(1), 25-36 DOI:10.29090/psa.2021.01.19.049
35. อธิศา ดำชะอม และ ศราวุฒิ อู่พุฒินันท์. (2563). ประสิทธิผลของโปรแกรมการบริบาลทางเภสัชกรรมเพื่อส่งเสริมความร่วมมือในการใช้ยาในผู้สูงอายุที่มีการได้รับยาหลายขนานในโรงพยาบาลชุมชนแห่งหนึ่งในจังหวัดกาญจนบุรี. วารสารเภสัชกรรมไทย, 12(3), 772-788.